The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Marketwire

BioExx Closes First Saskatoon Asset Sale for $3.5M

Monday, July 22, 2013

BioExx Closes First Saskatoon Asset Sale for $3.5M

07:00 EDT Monday, July 22, 2013

TORONTO, ONTARIO--(Marketwired - July 22, 2013) - BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX:BXI) today announced that it has closed its previously announced sale of certain equipment assets from its Saskatoon facility, for gross proceeds of $3.5 million.

Proceeds of the sale are being applied to a partial payment of a loan due to the Company's first secured creditor, with the balance allocated to working capital and general corporate purposes.

The previously announced second and final component of the planned Saskatoon asset sales, under which a purchaser will acquire the land, building, and certain canola crushing assets for $7.5 million, is expected to close on or about October 31, 2013. The closing is subject to customary terms, including environmental and structural inspections, completion of closing documentation, delivery of vacant possession after removal of the assets being sold to the first purchaser, and approval of secured creditors. BioExx intends to use the proceeds of that sale to fully repay its first secured creditor, with the balance allocated to working capital and general corporate purposes.

About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is focused on the separation of oil and high-value proteins from oilseeds for global food, beverage, nutrition, and other markets. BioExx employs trade secret, patented and patent-pending technologies to enable the improved separation of proteins from oilseeds. BioExx believes that these processes cumulatively have the potential to make a valuable contribution to global food and protein supply while maintaining an environmentally sustainable footprint.

To find out more about BioExx Specialty Proteins Ltd. (TSX:BXI), please visit www.bioexx.com.

The statements made in this press release include forward-looking statements that involve a number of risks and uncertainties. These statements relate to future events or future performance and reflect management's current expectations and assumptions. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, such as the economy, generally, competition in its target markets, the demand for BioExx's products, the availability of funding, the efficacy of its technology, and the anticipated costs of BioExx's plant construction and operation. Furthermore, there can be no guarantees that any agreement will be signed with a strategic partner. These forward-looking statements are made as of the date hereof and BioExx does not assume any obligation to update or revise them to reflect new events or circumstances. Actual events or results could differ materially from BioExx's expectations and projections.

FOR FURTHER INFORMATION PLEASE CONTACT:

Contact Information:
BioExx Specialty Proteins Ltd.
Chris Schnarr
Chief Executive Officer
(416) 588-4442 x111
cschnarr@bioexx.com
www.bioexx.com


TMX Equicom
Ross Marshall
Investor Relations
(416) 815-0700 x238
rmarshall@tmxequicom.com

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Advertising Privacy
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections